Imee Sinha
Research Subjects
Imee Sinha has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Andrew Martin Watkins
Genentech
1 shared publication - Franziska Seeger
Genentech
1 shared publication Henri Dwyer
1 shared publication- Homa MohammadiPeyhani
Prescient Design, Genentech
1 shared publication - Jack Bevers
Antibody Engineering, Genentech, South San Francisco, USA
1 shared publication - Joseph Kleinhenz
Prescient Design, Genentech, South San Francisco, CA, USA
1 shared publication
Latest Publications
- Open Access
CDR Conformation Aware Antibody Sequence Design with ConformAb
Antibody lead optimization methods seek to enhance a lead candidate's therapeutic properties through targeted sequence mutation. However, the mutations introduced during this process can inadvertently induce structural changes that disrupt binding, particularly by altering CDR loop conformations which destabilize CDR-target binding interactions. To address this, we present ConformAb, a guided discrete diffusion model for designing antibody sequences that explicitly conform to the CDR canonical conformation of the lead. With seed sequences as the starting point, we show that our method is capable of generating 3-5× better binders that conform to the same CDR backbone structure in a one-shot design setup, and in some cases, binders with better affinity than seed repertoire picks without any target-specific data included in training. Across the targets tested, ConformAb demonstrated binding rates ranging from 15-60% in wet lab experiments, a result obtained using fewer than 100 designs for each target. ConformAb offers a unique one-shot approach for antibody lead optimization in data-scarce scenarios where experimental/repertoire data cannot be leveraged for model training.
Open AccessCDR Conformation Aware Antibody Sequence Design with ConformAb
Antibody lead optimization methods seek to enhance a lead candidate's therapeutic properties through targeted sequence mutation. However, the mutations introduced during this process can inadvertently induce structural changes that disrupt binding, particularly by altering CDR loop conformations which destabilize CDR-target binding interactions. To address this, we present ConformAb, a guided discrete diffusion model for designing antibody sequences that explicitly conform to the CDR canonical conformation of the lead. With seed sequences as the starting point, we show that our method is capable of generating 3-5× better binders that conform to the same CDR backbone structure in a one-shot design setup, and in some cases, binders with better affinity than seed repertoire picks without any target-specific data included in training. Across the targets tested, ConformAb demonstrated binding rates ranging from 15-60% in wet lab experiments, a result obtained using fewer than 100 designs for each target. ConformAb offers a unique one-shot approach for antibody lead optimization in data-scarce scenarios where experimental/repertoire data cannot be leveraged for model training.